HMGB1 and triple-A syndrome: Substantial evidence indicates that chronic inflammation anddysregulation of the ECM are key factors in the development of AAA, thuspresenting a possible therapeutic strategy for controlling its progression [34].Our study found that elevated serum HMGB2 and HMGB1 levels were bothindependently associated with the incidence and rupture of AAA in males.